Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.
Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic.
People living with both viruses remain at risk for hepatocellular carcinoma despite antiviral therapy.
The disease has similar prevalence across high-income and low- and middle-income nations.
Unexpectedly, liver steatosis was also associated with a greater chance of achieving HBsAg seroclearance.
Alcoholism-related liver disease was a growing problem even before COVID-19, but the pandemic has dramatically added to the toll.
Blue Faery’s “Love Your Liver” 28-day video campaign raises awareness of liver cancer and overall liver health.
Hepatitis A and E usually resolve on their own, but hepatitis B and C can cause serious liver disease, including cirrhosis and liver cancer.
Compared to other racial and ethnic groups, Blacks are also less likely to be diagnosed early.
Treatment with Tecentriq plus Avastin or with Keytruda alone delays disease progression and improves survival.
The decrease is largely due to improved lung cancer treatment, but the impact of COVID-19 is not yet known.
A Mediterranean diet could help reduce the risk of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
COVID-19, FDA drug approvals and new approaches to treatment and quality of life stood out among this year’s top stories.
A study comparing matched groups of people with and without HIV found that smoking was a powerful cancer risk factor, especially for women.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.